SBSierra M. Brooks

Sierra M. Brooks

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sierra M. Brooks has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Bioproduction, bioprotection, and biocontainment in multi-Kingdom microbial systems with 3D spatial control

    by LeAnn Le, Gokce Altin-Yavuzarslan, Elizabeth C Klatt, Naroa Sadaba, Angus C Berg, Ava V Karanjia, Sierra M Brooks, Jesse G Zalatan, Lilo D. Pozzo, James Carothers, et al.

    Engineered living materials (ELMs) are a class of hybrid materials that include engineered microbes encapsulated by a polymer matrix. The biotic and abiotic components define the ELMs design space and can be altered to improve performance and function. While current synthetic materials in the field display robust biocompatibility with both native and engineered living systems, we have a limited understanding of how to leverage 3D form factors to spatially organize and control microbial dynamics within the material. Motivated by this knowledge gap, we employed extrusion-based 3D printing to fabricate multi-material hydrogel constructs for the encapsulation of both single and dual-microbial systems. Core-shell cubic constructs enabled the spatial organization of a constitutive multi-kingdom system of levodopa (L-DOPA)-producing E. coli and betaxanthins-producing S. cerevisiae. This deliberate spatial organization in 3D materials can introduce precise control over bioproduction, bioprotection, and biocontainment, features that are critical to the efficacy of current ELMs. The relative spatial organization of the organisms, as well as the surface area-to-volume ratio were investigated to determine how these design elements impact microbial behavior (metabolite production, growth, expression and cell distribution) over time. We demonstrated that F127-BUM core-shell geometries enable the hierarchical 3D printing of multi-kingdom constructs, offering customizable control over bioproduction, bioprotection, and biocontainment. With the optimization of these core-shell structures for continuous bioproduction, these ELMs could be deployed as compact, sustainable bioreactors in remote environments.


  • Theranostic Probiotic Engineered Living Materials That Dynamically Respond to Inflammation Markers

    by Gokce Altin‐Yavuzarslan, Sierra M. Brooks, James O. Park, Kevin B. Reed, McKenna Flynn, Olivia L. Lanier, Hongyuan Lu, Hal S. Alper, Alshakim Nelson

    The development of smart, implantable devices localized at the site of inflammation to conditionally and proactively combat active inflammation for inflammatory bowel disease (IBD), has the potential to transform the patient's quality of life compared to conventional treatment modalities. Engineered probiotic organisms can enable dynamic production of therapeutic compounds in response to inflammatory biomarkers. However, delivery and localization of these engineered organisms to the site of inflammation requires their integration into a material or device that sustains their viability and metabolic activity. To this end, a 3D printed engineered living material (ELM) is developed using an engineered probiotic organism ( E. coli Nissle 1917) with genetic circuits to sense biomarkers for inflammation and respond with the production of anti‐inflammatory compounds. These organisms are incorporated into poly(ethylene glycol) diacrylate (PEGDA) resins for the light‐based 3D printing of 3D constructs. The organisms are physically encapsulated within the PEGDA and are fully viable and metabolically active. The 3D printed ELM devices are able to detect clinically relevant amounts of nitric oxide as an inflammatory biomarker and respond with the production of tryptamine or 1‐acetyl‐3‐carboxyl‐β‐carboline as representative anti‐inflammatory agents. Additionally, the ELM devices are efficacious in treating in vitro models of inflammation, including murine macrophages and intestinal epithelial cells. Looking forward, these ELM devices could serve as theranostic modalities for the long‐term treatment of inflammatory disorders such as IBD.


  • Open Access

    Author Correction: A modular and synthetic biosynthesis platform for de novo production of diverse halogenated tryptophan-derived molecules

    by Kevin B. Reed, Sierra M. Brooks, Jordan Wells, Kristin J. Blake, Minye Zhao, Kira Placido, Simon D’oElsnitz, Adit Trivedi, Shruti Gadhiyar, Hal S. Alper


  • Open Access

    A modular and synthetic biosynthesis platform for de novo production of diverse halogenated tryptophan-derived molecules

    by Kevin B. Reed, Sierra M. Brooks, Jordan Wells, Kristin J. Blake, Minye Zhao, Kira Placido, Simon D’oelsnitz, Adit Trivedi, Shruti Gadhiyar, Hal S. Alper

    Halogen-containing molecules are ubiquitous in modern society and present unique chemical possibilities. As a whole, de novo fermentation and synthetic pathway construction for these molecules remain relatively underexplored and could unlock molecules with exciting new applications in industries ranging from textiles to agrochemicals to pharmaceuticals. Here, we report a mix-and-match co-culture platform to de novo generate a large array of halogenated tryptophan derivatives in Escherichia coli from glucose. First, we engineer E. coli to produce between 300 and 700 mg/L of six different halogenated tryptophan precursors. Second, we harness the native promiscuity of multiple downstream enzymes to access unexplored regions of metabolism. Finally, through modular co-culture fermentations, we demonstrate a plug-and-play bioproduction platform, culminating in the generation of 26 distinct halogenated molecules produced de novo including precursors to prodrugs 4-chloro- and 4-bromo-kynurenine and new-to-nature halogenated beta carbolines.


  • Engineered Living Material Bioreactors with Tunable Mechanical Properties using Vat Photopolymerization

    by Gokce Altin‐Yavuzarslan, Naroa Sadaba, Sierra M. Brooks, Hal S. Alper, Alshakim Nelson

    3D‐printed engineered living materials (ELM) are promising bioproduction platforms for agriculture, biotechnology, sustainable energy, and green technology applications. However, the design of these platforms faces several challenges, such as the processability of these materials into complex form factors and control over their mechanical properties. Herein, ELM are presented as 3D‐printed bioreactors with arbitrary shape geometries and tunable mechanical properties (moduli and toughness). Poly(ethylene glycol) diacrylate (PEGDA) is used as the precursor to create polymer networks that encapsulate the microorganisms during the vat photopolymerization process. A major limitation of PEGDA networks is their propensity to swell and fracture when submerged in water. The authors overcame this issue by adding glycerol to the resin formulation to 3D print mechanically tough ELM hydrogels. While polymer concentration affects the modulus and reduces bioproduction, ELM bioreactors still maintain their metabolic activity regardless of polymer concentration. These ELM bioreactors have the potential to be used in different applications for sustainable architecture, food production, and biomedical devices that require different mechanical properties from soft to stiff.


  • Open Access

    A tripartite microbial co-culture system for de novo biosynthesis of diverse plant phenylpropanoids

    by Sierra M. Brooks, Celeste Marsan, Kevin B. Reed, Shuo-Fu Yuan, Dustin-Dat Nguyen, Adit Trivedi, Gokce Altin-Yavuzarslan, Nathan Ballinger, Alshakim Nelson, Hal S. Alper

    Plant-derived phenylpropanoids, in particular phenylpropenes, have diverse industrial applications ranging from flavors and fragrances to polymers and pharmaceuticals. Heterologous biosynthesis of these products has the potential to address low, seasonally dependent yields hindering ease of widespread manufacturing. However, previous efforts have been hindered by the inherent pathway promiscuity and the microbial toxicity of key pathway intermediates. Here, in this study, we establish the propensity of a tripartite microbial co-culture to overcome these limitations and demonstrate to our knowledge the first reported de novo phenylpropene production from simple sugar starting materials. After initially designing the system to accumulate eugenol, the platform modularity and downstream enzyme promiscuity was leveraged to quickly create avenues for hydroxychavicol and chavicol production. The consortia was found to be compatible with Engineered Living Material production platforms that allow for reusable, cold-chain-independent distributed manufacturing. This work lays the foundation for further deployment of modular microbial approaches to produce plant secondary metabolites.


  • Open Access

    Gene expression dynamics in input-responsive engineered living materials programmed for bioproduction

    by Widianti Sugianto, Gokce Altin-Yavuzarslan, Benjamin I. Tickman, Cholpisit Kiattisewee, Shuo-Fu Yuan, Sierra M. Brooks, Jitkanya Wong, Hal S. Alper, Alshakim Nelson, James M. Carothers


  • Open Access

    Bioproduced Proteins On Demand (Bio-POD) in hydrogels using Pichia pastoris

    by Shuo-Fu Yuan, Sierra M. Brooks, Annalee W. Nguyen, Wen-Ling Lin, Trevor G. Johnston, Jennifer A. Maynard, Alshakim Nelson, Hal S. Alper

    Traditional production of industrial and therapeutic proteins by eukaryotic cells typically requires large-scale fermentation capacity. As a result, these systems are not easily portable or reusable for on-demand protein production applications. In this study, we employ Bioproduced Proteins On Demand (Bio-POD), a F127-bisurethane methacrylate hydrogel-based technique that immobilizes engineered Pichia pastoris for preservable, on-demand production and secretion of medium- and high-molecular weight proteins (in this case, SEAP, α-amylase, and anti-HER2). The gel samples containing encapsulated-yeast demonstrated sustained protein production and exhibited productivity immediately after lyophilization and rehydration. The hydrogel platform described here is the first hydrogel immobilization using a P. pastoris system to produce recombinant proteins of this breadth. These results highlight the potential of this formulation to establish a cost-effective bioprocessing strategy for on-demand protein production.


  • Top Cited Papers
    Open Access

    Applications, challenges, and needs for employing synthetic biology beyond the lab

    by Sierra M. Brooks, Hal S. Alper

    Synthetic biology holds great promise for addressing global needs. However, most current developments are not immediately translatable to ‘outside-the-lab’ scenarios that differ from controlled laboratory settings. Challenges include enabling long-term storage stability as well as operating in resource-limited and off-the-grid scenarios using autonomous function. Here we analyze recent advances in developing synthetic biological platforms for outside-the-lab scenarios with a focus on three major application spaces: bioproduction, biosensing, and closed-loop therapeutic and probiotic delivery. Across the Perspective, we highlight recent advances, areas for further development, possibilities for future applications, and the needs for innovation at the interface of other disciplines.